Related Experiment Video
Updated: May 11, 2026

Use of a Low-flow Digital Anesthesia System for Mice and Rats
Published on: September 7, 2016
Shrinking pharmacological options in modern anaesthesia
Daniel Chappell1, Peter Kranke2
1Department of Anaesthesiology and Critical Care Medicine, Varisano Hospital Frankfurt Höchst, Frankfurt, Germany.
Abstract:
Anaesthesia has become progressively safer through standardisation, technological advances, and pharmacological refinement. Paradoxically, the practical diversity of anaesthetic drugs available for routine clinical use is narrowing because of regulatory decisions, environmental policies, procurement pressures, market withdrawals, and professional convergence on default regimens. Although standardisation improves reliability, excessive pharmacological contraction can reduce clinical resilience, erode training competence with alternative agents, and increase vulnerability to shortages or context-specific contraindications. Stimulated by recent commentary that desflurane abandonment is only one component of a comprehensive sustainability strategy in anaesthesia, we argue that pharmacological diversity represents a form of preparedness: maintaining second-line and context-specific options is not inefficiency but a safeguard for patient-centred, adaptable care.
More Related Videos
Related Concept Videos
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Local Anesthetics: Pharmacokinetics
Local Anesthetics: Clinical Application as Spinal Anesthesia

